Showing 1 - 17 results of 17 for search 'neuro-oncology', query time: 0.06s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Radiomics and Radiogenomics in Differentiating Progression, Pseudoprogression, and Radiation Necrosis in Gliomas by Sohil Reddy, Tyler Lung, Shashank Muniyappa, Christine Hadley, Benjamin Templeton, Joel Fritz, Daniel Boulter, Keshav Shah, Raj Singh, Simeng Zhu, Jennifer K. Matsui, Joshua D. Palmer

    Published 2025-07-01
    “…This review underscores radiomics and radiogenomics’ potential to revolutionize glioma management, marking a significant shift towards precision neuro-oncology.…”
    Get full text
    Article
  13. 13

    The risk of venous thromboembolism in adult patients with diffuse glioma: a nationwide population-based study by Frederik R. Hovman, Frantz R. Poulsen, Steinbjørn Hansen, Rikke H. Dahlrot

    Published 2024-11-01
    “…Materials and methods: In total 3,630 patients with WHO grade 2 (n = 230), grade 3 (n = 317), and grade 4 (n = 3,083) gliomas from 2010 to 2018 were identified using the Danish Neuro-Oncology Registry. VTE diagnoses and time of death were obtained from Statistics Denmark. …”
    Get full text
    Article
  14. 14

    Surgical treatment of patients with multiple brain metastases by D. M. Belov, V. B. Karakhan, A. Kh. Bekyashev, E. V. Mitrofanov, E. V. Prozorenko, V. A. Aleshin, R. A. Sufianov, D. R. Nashletashvili

    Published 2024-06-01
    “…The study included 40 patients with single and multiple cerebral metastases who underwent neurosurgical intervention in the neuro-oncology department of the N.N. Blokhin National Medical Oncology Research Center from 2010 to 2022.Results. …”
    Get full text
    Article
  15. 15
  16. 16
  17. 17

    FLOW CYTOMETRY IN THE DEVELOPMENT AND CHARACTERIZATION OF PRECLINICAL TUMOR MODELS BASED ON THE ANALYSIS OF EXTRACELLULAR VESICLES AS CANDIDATE LIQUID BIOMARKERS

    Published 2025-08-01
    “…The molecular profiling of brain tumors has become an integral component of routine neuro-oncologic care. Currently, it is mainly achieved through invasive procedures such as tissue biopsy and surgical resection, often associated with complications and especially challenging. …”
    Get full text
    Article